What is the CPT (Current Procedural Terminology) code for an ultrasound to monitor the liver in a patient with cirrhosis of the liver?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CPT Code for Liver Ultrasound Monitoring in Cirrhosis

The CPT code for ultrasound monitoring of the liver in a patient with cirrhosis is 76700 (Ultrasound, abdominal, real time with image documentation; complete) or 76705 (limited), depending on whether a complete or limited examination is performed.

Standard Surveillance Protocol

Patients with cirrhosis require ultrasound surveillance every 6 months for hepatocellular carcinoma (HCC) screening. 1, 2 This recommendation is based on the American Association for the Study of Liver Diseases guidelines, which establish ultrasound as the primary surveillance modality for HCC detection in cirrhotic patients. 1, 2

CPT Code Selection

  • CPT 76700 is used for a complete abdominal ultrasound with real-time imaging and documentation, which includes comprehensive evaluation of the liver, gallbladder, bile ducts, pancreas, spleen, and kidneys. 3

  • CPT 76705 is used for a limited ultrasound examination focused specifically on the liver when a complete abdominal survey is not clinically indicated.

  • The choice between complete versus limited examination depends on whether you need to assess for cirrhosis complications (ascites, splenomegaly, portal hypertension) or are performing focused HCC surveillance only.

Important Coding Considerations

When ultrasound quality is inadequate, alternative imaging must be pursued. 1, 3, 2 The American College of Radiology specifically notes that ultrasound is particularly limited in patients with obesity, nonalcoholic fatty liver disease, and nodular cirrhotic livers. 1, 3 In these populations, multiphase CT (CPT 74170) or MRI (CPT 74181-74183) should be considered instead. 1, 2

Additional Codes That May Apply

  • CPT 91200 (Liver elastography) may be added when assessing fibrosis progression, though this is typically not part of routine HCC surveillance. 1

  • Alpha-fetoprotein (AFP) testing (CPT 82105) is optional but commonly added to ultrasound surveillance, though guidelines consider it adjunctive rather than mandatory. 1

Common Pitfalls to Avoid

  • Do not accept "limited visualization" reports without follow-up imaging. 3, 2 When radiologists report inadequate visualization, you must pursue CT or MRI to avoid missing early HCC, as ultrasound sensitivity drops to only 47% for early-stage disease. 2

  • Do not extend surveillance intervals beyond 6 months. 1, 2 This is the evidence-based standard for all cirrhotic patients regardless of etiology or other risk factors.

  • Recognize that ultrasound has inherent limitations - it achieves only 65-80% sensitivity for HCC detection overall and cannot reliably diagnose earlier stages of fibrosis. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Imaging Evaluation of Hepatocellular Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Liver Ultrasound Scanning Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.